There is growing interest in the use of oral antidiabetic agents, including glyburide and metformin, because of increased convenience and potential cost savings. Based on favorable clinical trial data and evidence that it has minimal transfer across the placenta, glyburide is recommended by some experts as an alternative for women who are unable or unwilling to take insulin. However as of November 2013, none of the oral agents is FDA approved for use in pregnancy.